Yesterday, but the U.S. Treatment Services Task Force announced that leeches aren’t a particularly good treatment for most ailments. While noting that leeches might still be useful for certain specific circulation disorders, the USTSTF recommended against their use in other situations, like treating fever and abdominal pains.

Although the Task Force has no power to make anyone do anything, Rep. Dave Camp (R-Mich) was heard on NPR’s Morning Edition saying, “Some people discounted the idea that the government would actually put people to death … this actually is really showing how the insidious encroachment of government between the patient and their doctor plays out.” Camp neglected to address the facts: (1) overuse of leeches is expensive, and science-based recommendations about appropriate use would save the government money without harming patients, and (2) bloodletting can lead to negative side effects, such as upsetting the body’s natural humoral balance.

Widespread concern of regular citizens that leeches would no longer be offered by their doctors, was shared by industry leaders. “I am deeply concerned about the actions of the USTSTF in severely limiting access to leeches. These recommendations, in combination with recent Medicare cuts to leech reimbursement, jeopardizes access to both long proven and cutting-edge bloodletting technologies,” stated James H. Thrall, M.D., FACR, Chair of the American College of Bloodletting Board of Chancellors. Dr. Thrall neglected to note that the USTSTF did not limit access to anything, and merely made a recommendation.

Fortunately, the Secretary of Health and Human Services rushed to the microphone to pledge for the record that there would be no changes to Medicare or Medicaid coverage while she was on the job. “My message to patients is simple. Leeches have always been an important life-saving tool in the fight against pretty much any sickness they still are today. Keep doing what you have been doing for years — talk to your doctor about your individual history, ask questions, and make the decision that is right for you.”

Few commentators highlighted the rigorous science-based process of the USTSTF, the evidence against leech use in most cases, and the harms caused by the excessive use of leeches to treat illnesses ranging from halitosis to flatulence.

Aron Boros is a lawyer and health policy analyst in Boston, Massachusetts.

4 Responses for “This Just In”

  1. gdr says:

    thanks for the smile. I needed it. So many idiots and self-interested a$$es willing to take advantage. Have they no shame – no sense of decency? No. And I don’t know how much longer I will be able to remain in this world because of it.

  2. Hilly says:

    Hey! Leeches saved my sister’s life! Haha, very funny piece and highly relevant to this debate.

  3. DrBurr says:

    I hear they will next be rationing cupping and mercury for the treatment of syphylis. I am enraged at this government intrusion between me and my doctor!

  4. MD as HELL says:

    I hear there is a shortage of leaches. Too many of them are in Congress and they do not want to quit sucking dry the country, even though the country is bleeding to death.

Leave a Reply

THCB ADS




MASTHEAD


Matthew Holt
Founder & Publisher

John Irvine
Executive Editor

Jonathan Halvorson
Editor

Alex Epstein
Director of Digital Media

Munia Mitra, MD
Editor, Business of Healthcare

Laura Montini
Associate Editor

Cindy Williams
Associate Editor

Michael Millenson
Contributing Editor










About Us | Media Guide
© THCB 1995-2012
WRITE FOR US

We're looking for bloggers. Send us your posts.

If you've had a recent experience with the U.S. health care system, either for good or bad, that you want the world to know about, tell us.

Have a good health care story you think we should know about? Send story ideas and tips to tips@thehealthcareblog.com.

ADVERTISE

Want to reach a dedicated audience of healthcare insiders and industry observers? THCB reaches a monthly audience of 100,000 movers and shakers. We reach a total circulation of roughly 450,000. Find out about advertising options here.

Questions on reprints, permissions and syndication to ad_sales@thehealthcareblog.com.

THCB CLASSIFIEDS

Reach a super targeted healthcare audience with your text ad. Target physicians, health plan execs, health IT and other groups with your message.
ad_sales@thehealthcareblog.com
WORK FOR US:

Interested in the intersection of healthcare, technology and business? We're looking for talented interns to work in our San Francisco offices. Get in touch.

Wordpress guru? We're looking for a part time web-developer to help take THCB to the next level. Drop us a line.

SUPPORT:

Let us know about a glitch or a technical problem.

Report spam or abuse here.
SEND US STUFF:

THCB
650 Delancey Street
San Francisco, California 94107

Other stuff you can do:

Subscribe to our RSS feed
Get THCB via Email
Follow us on Twitter
Like us on Facebook